ROSS Announces CDA-200 Dual Shaft Mixer for Processing Viscous Pharmaceuticals

Why It Matters

The mixer enables large‑scale, high‑viscosity drug production with lower contamination risk and faster cycle times, giving pharma manufacturers a competitive edge in efficiency and compliance.

Key Takeaways

• Processes up to 200 gallons per batch.
• Handles viscosities up to 500,000 cP.
• No submerged bearings, reducing contamination risk.
• Vacuum up to 29.5 in Hg minimizes air entrapment.
• Teflon scrapers boost heat transfer and cleaning.

Pulse Analysis

The pharmaceutical industry increasingly formulates high‑viscosity suspensions, emulsions and biologics that strain conventional mixers. Viscous blends often suffer from uneven dispersion, excessive shear heating, and trapped air, which can compromise dose uniformity and stability. ROSS’s CDA‑200 Dual Shaft Mixer enters the market as a purpose‑built solution, offering a 10‑hp anchor agitator paired with a high‑speed disperser capable of 1,600 RPM. By delivering a vortex of 5,000 ft min⁻¹, the system rapidly wets dry actives, ensuring consistent particle distribution across batches as large as 200 gallons.

Contamination control is paramount in GMP environments, and the CDA‑200 eliminates submerged bearings and seals, creating a clean product zone. Stainless‑steel 304 jackets and interchangeable Teflon scrapers provide precise thermal management for heat‑sensitive APIs, while a hydraulic lift enables rapid change‑can operations. Integrated vacuum capability of up to 29.5 in Hg removes entrapped gases, reducing bubble formation that can affect viscosity and downstream processing. Safety limit switches and a 7‑inch color touchscreen interface allow customizable interlocks and real‑time monitoring, helping facilities meet both classification and validation requirements without extensive retrofits.

The CDA‑200’s capacity and flexibility position it as a catalyst for scaling continuous‑manufacturing lines, where batch sizes must expand without sacrificing quality. By combining high‑speed dispersion with robust agitation, manufacturers can reduce cycle times and lower energy consumption compared with separate mixing and homogenizing units. The equipment’s modular design also aligns with Industry 4.0 initiatives, enabling data collection from VFDs and temperature sensors for predictive maintenance and process analytics. As regulators tighten standards for aseptic processing, mixers that minimize cleaning cycles while delivering consistent performance, like the CDA‑200, will become strategic assets in competitive pharma pipelines.